此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Neuroinflammation, Serotonin, Impulsivity and Suicide (NISIS)

2016年6月30日 更新者:University Hospital, Montpellier

Suicide is a major health problem that causes annually a million death worlwide. In the stress-vulnerability model, suicidal behavior (SB) results from the interaction between an individual's predisposition (personality, family history of SB…) and stressful conditions (early life adversity).

Studies show that suicide ideations could favour inflammation and that depression is associated with an elevated inflammation.

Recent evidences also suggest that inflammatory mediators play a critical role in SB.

The aim of the study is to evaluate the inflammatory markers rate on depressed patients with or without personal history of SB.

In the second part of the study, the relations between the rates of inflammatory markers and characteristics of SB, impulsivity, psychological pain, childhood abuse and gene expression of 5HT2B receptor will be investigated.

研究概览

地位

未知

详细说明

Over one year, we will recruit 280 patients suffering from a major depressive episode with (n=140) and without any history of suicide attempt (n=140), from a specialized clinic for mood disorders and SB.

First visit : clinical, biological and neuropsychological assessment

Second visit, at 6 month : Follow-up visit in the department or interview by telephone in order to assess suicidal ideations or suicide attempts since the inclusion.

研究类型

介入性

注册 (预期的)

280

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Montpellier、法国、34295
        • 招聘中
        • University Hospital
        • 接触:

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 65年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Ages of 18 and 65
  • Main diagnosis of major depressive episode (DSM-IV criteria)
  • Having signed the informed consent
  • Able to understand nature, aims, and methodology of the study

Specifics Inclusion criteria:

  • Depressed patients with suicide attempt history :

    • Have done in his lifetime at least one suicide attempt (however the period of time between inclusion and suicide attempt)
  • Depressed patients without suicide attempt history :

    • Had never realized suicide attempt in his lifetime

Exclusion Criteria:

  • Patients suffering from inflammatories pathology
  • Antibiotic or anti-inflammatory current treatment
  • Pregnancy
  • Participation in another clinical trial with an exclusion period
  • Patient on protective measures (guardianship or trusteeship)

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 分配:不适用
  • 介入模型:单组作业
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
其他:Depressive patients
Blood samples (inflammatory biomarkers and genetic purpose) on depressive patients with or without story of suicidal behavior
Blood sample in order to study inflammatory biomarkers and genetics purpose

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Rate of interleukin 2 (Il2) in a blood sample
大体时间:inclusion visit
Comparison of Il2 levels between patients with and without suicidal behaviour
inclusion visit

次要结果测量

结果测量
措施说明
大体时间
Rate of inflammation markers (Interleukin 1, 4, 6, 8, 10, Tumor necrosis factor alpha (TNF-a), Interferon gamma (IFNg), Vascular endothelial growth factor (VEGF), kynurenin and c-reactive protein (CRP) in a blood sample
大体时间:inclusion visit
Comparison of the levels of theses markers between patients with and without suicidal behaviour
inclusion visit
Rate of inflammation markers and suicide attempt
大体时间:inclusion visit
Comparison of rate bloodmarkers inflammation (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) in depressed patients with latest suicide attempt and depressed patients with an history of suicide attempt
inclusion visit
Rate of inflammation markers and violent suicide attempt
大体时间:inclusion visit
Comparison of rate bloodmarkers inflammation (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) in depressed patients with and without violent suicide attempt
inclusion visit
Rate of inflammation markers and suicide ideations
大体时间:inclusion visit
Comparison of rate bloddmarkers (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) in depressed patients with and without current suicide ideation
inclusion visit
Relation between markers of inflammation and suicidal behavior characteristics
大体时间:inclusion visit
Studying relations with bloodmarkers inflammation rate (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) and suicidal behaviour characteristics (the last and the most serious) (intentionality, planification, lethality)
inclusion visit
Relation between markers of inflammation and impulsivity
大体时间:inclusion visit
Studying relations with bloodmarkers inflammation rate (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) and impulsivity (by Baratt Impulsivity Scale and neuropsychological tests)
inclusion visit
Relation between markers of inflammation and psychological pain
大体时间:inclusion visit
Studying relations with bloodmarkers inflammation rate (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) and psychological pain (by Likert scale)
inclusion visit
Relation between markers of inflammation and child abuse
大体时间:inclusion visit
Studying relations with bloodmarkers inflammation rate (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) and child abuse
inclusion visit
Relation between markers of inflammation and gene expression
大体时间:inclusion visit
Studying relations with bloodmarkers inflammation rate (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) and gene expression of 5HT2B receptor
inclusion visit
Markers of inflammation as a risk factor for suicidal behavior
大体时间:at 6 months
Studying bloodmarkers inflammation rate (Il1, 4, 6, 8, 10, TNF-a, IFNg, VEGF, kynurenine and CRP) as suicidal behaviour risk factor (suicide ideations and/or suicide attempt) with a 6 months follow-up.
at 6 months

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2015年11月1日

初级完成 (预期的)

2017年5月1日

研究完成 (预期的)

2017年11月1日

研究注册日期

首次提交

2016年6月30日

首先提交符合 QC 标准的

2016年6月30日

首次发布 (估计)

2016年7月6日

研究记录更新

最后更新发布 (估计)

2016年7月6日

上次提交的符合 QC 标准的更新

2016年6月30日

最后验证

2016年6月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • UF9467
  • 2014-A01313-44 (其他标识符:ANSM)

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅